Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...

The Insulin Pumps & Continuous Glucose Monitors market offers significant opportunities in strategic planning, supply chain management, and investment decisions. Key trends include evolving ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...

Immunocore is expanding its ImmTAX platform into autoimmune disease, outlining plans at the 44th Annual JP Morgan Healthcare ...

SAN FRANCISCO – Alteogen, the most valuable biotech firm listed on Korea’s tech-heavy Kosdaq, is nearing another major ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous ...

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

ATTR program on hold amid safety risks; HAE therapy faces tough rivals and small market. Read more analysis here.

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...